InsiderClue
← All stocks

Roivant Sciences Ltd.

ROIV Net selling
CIK 0001635088 #653 in the set updated 17 Sep 2026
Bought (12 mo)
$49.96K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$922.14M
$9.06M on a plan · $415.87M straight out of an exercise
Sold at will
$497.21M
64 of 119 sales
Net
−$922.09M
−$497.16M against sales at will

By person

15 insiders · 120 transactions
916×

Matthew Gline holds 916 times base salary in stock. $664.73M of shares against $725.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Gline last reported holding, valued at $39.90, the price Common Shares was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MANCHESTER KEITH S
Director
—
$154.47M (20)
−$154.47M
15,437,569
2.14%
$615.96M
−60.6%
Gold Daniel Allen
Director
—
$147.38M (19)
−$147.38M
22,649,927
3.14%
$903.73M
−67.4%
QVT Financial LP entity
Director by Deputization
—
$147.38M (19)
−$147.38M
13,689,166
1.90%
$546.20M
−76.0%
Venker Eric
President & Immunovant CEO
—
$115.29M (26) scheduled
−$115.29M
1,599,154
0.2214%
$63.81M
+150.1%
Sukhatme Mayukh
President & CIO
—
$109.13M (13) scheduled
−$109.13M
18,630,739
2.58%
$743.37M
−17.2%
Ramaswamy Vivek
10% owner
—
$105.88M (6) scheduled
−$105.88M
47,011,612
6.51%
$1.88B
−12.0%
Torti Frank
President and Vant Chair
—
$82.04M (3) scheduled
−$82.04M
13,536,202
1.87%
$540.09M
—
Gline Matthew
CEO
$49.96K (1)
$46.17M (4) scheduled
−$46.12M
16,659,945
2.31%
$664.73M
−9.0%
Pulik Richard
CFO
—
$9.12M (2) scheduled
−$9.12M
271,810
0.0376%
$10.85M
−5.9%
Fitzgerald Meghan
Director
—
$3.07M (3) scheduled
−$3.07M
41,220
0.0057%
$1.64M
+40.3%
Epperly Melissa B,
Director
—
$1.81M (3)
−$1.81M
14,838
0.0021%
$592.04K
−59.3%
Humes Jennifer
Chief Accounting Officer
—
$384.07K (1)
−$384.07K
109,782
0.0152%
$4.38M
—
Kumar Rakhi
Chief Accounting Officer
—
—
—
162,306
0.0225%
$6.48M
−23.6%
Oren Ilan
Director
—
—
—
118,626
0.0164%
$4.73M
+24.1%
MOMTAZEE JAMES C
Director
—
—
—
106,905
0.0148%
$4.27M
+15.7%

Individual transactions

120
Insider
Date
Role
Action
Shares
Price
Amount
Fitzgerald Meghan
8 Sep 2026
Director
Sold after exercise
20,000
$39.90
$798.00K
Venker Eric
28 Aug 2026
President & Immunovant CEO
Sold after exercise
33,818
$36.44
$1.23M
Venker Eric
28 Aug 2026
President & Immunovant CEO
Sold after exercise
166,182
$35.63
$5.92M
Sukhatme Mayukh
21 Aug 2026
President & CIO
Sold after exercise
144,756
$36.48
$5.28M
Sukhatme Mayukh
20 Aug 2026
President & CIO
Sold after exercise
17,519
$37.30
$653.46K
Sukhatme Mayukh
19 Aug 2026
President & CIO
Sold after exercise
172,899
$37.17
$6.43M
Sukhatme Mayukh
18 Aug 2026
President & CIO
Sold after exercise
31,801
$37.18
$1.18M
Sukhatme Mayukh
18 Aug 2026
President & CIO
Sold after exercise
105,141
$36.59
$3.85M
Sukhatme Mayukh
17 Aug 2026
President & CIO
Sold after exercise
284,707
$36.25
$10.32M
Sukhatme Mayukh
14 Aug 2026
President & CIO
Sold after exercise
243,177
$36.23
$8.81M
Venker Eric
27 Jul 2026
President & Immunovant CEO
Sold after exercise
200,000
$34.95
$6.99M
QVT Financial LP
30 Jun 2026
Director by Deputization
Sell indirect
12,380
$35.28
$436.77K
Gold Daniel Allen
30 Jun 2026
Director
Sell indirect
12,380
$35.28
$436.77K
MANCHESTER KEITH S
30 Jun 2026
Director
Sell
200,000
$35.45
$7.09M
MANCHESTER KEITH S
30 Jun 2026
Director
Sell indirect
12,380
$35.28
$436.77K
Fitzgerald Meghan
30 Jun 2026
Director
Sold after exercise
10,000
$34.90
$349.00K
QVT Financial LP
29 Jun 2026
Director by Deputization
Sell indirect
600,000
$34.59
$20.75M
QVT Financial LP
29 Jun 2026
Director by Deputization
Sell indirect
200,000
$34.44
$6.89M
Gold Daniel Allen
29 Jun 2026
Director
Sell indirect
600,000
$34.59
$20.75M
Gold Daniel Allen
29 Jun 2026
Director
Sell indirect
200,000
$34.44
$6.89M
MANCHESTER KEITH S
29 Jun 2026
Director
Sell indirect
600,000
$34.59
$20.75M
MANCHESTER KEITH S
29 Jun 2026
Director
Sell indirect
200,000
$34.44
$6.89M
Epperly Melissa B,
29 Jun 2026
Director
Sold after exercise
2,748
$34.71
$95.38K
Epperly Melissa B,
29 Jun 2026
Director
Sold after exercise
15,002
$34.32
$514.87K
Sukhatme Mayukh
26 Jun 2026
President & CIO
Sold after exercise
500,000
$34.08
$17.04M
QVT Financial LP
26 Jun 2026
Director by Deputization
Sell indirect
325,000
$34.07
$11.07M
QVT Financial LP
26 Jun 2026
Director by Deputization
Sell indirect
300,783
$33.92
$10.20M
Gold Daniel Allen
26 Jun 2026
Director
Sell indirect
325,000
$34.07
$11.07M
Gold Daniel Allen
26 Jun 2026
Director
Sell indirect
300,783
$33.92
$10.20M
MANCHESTER KEITH S
26 Jun 2026
Director
Sell indirect
325,000
$34.07
$11.07M
MANCHESTER KEITH S
26 Jun 2026
Director
Sell indirect
300,783
$33.92
$10.20M
Sukhatme Mayukh
25 Jun 2026
President & CIO
Sold after exercise
500,000
$34.13
$17.07M
Venker Eric
24 Jun 2026
President & Immunovant CEO
Sold after exercise
46,234
$33.51
$1.55M
Venker Eric
24 Jun 2026
President & Immunovant CEO
Sold after exercise
153,766
$33.05
$5.08M
Venker Eric
22 May 2026
President & Immunovant CEO
Sold after exercise
200,000
$30.27
$6.05M
Venker Eric
20 Apr 2026
President & Immunovant CEO
Sold after exercise
200,000
$29.59
$5.92M
Gline Matthew
16 Apr 2026
CEO
Sell
289,774
$29.16
$8.45M
Humes Jennifer
8 Apr 2026
Chief Accounting Officer
Sell
13,538
$28.37
$384.07K
Fitzgerald Meghan
26 Mar 2026
Director
Sold after exercise
70,000
$27.45
$1.92M
Venker Eric
17 Mar 2026
President & Immunovant CEO
Sold after exercise
200,000
$28.24
$5.65M
Epperly Melissa B,
16 Mar 2026
Director
Sell
41,861
$28.68
$1.20M
Torti Frank
23 Feb 2026
President and Vant Chair
Sold after exercise
587,390
$27.51
$16.16M
Torti Frank
20 Feb 2026
President and Vant Chair
Sold after exercise
1,012,610
$27.15
$27.49M
Torti Frank
19 Feb 2026
President and Vant Chair
Sold after exercise
1,400,000
$27.42
$38.39M
QVT Financial LP
13 Feb 2026
Director by Deputization
Sell indirect
225,000
$26.50
$5.96M
QVT Financial LP
13 Feb 2026
Director by Deputization
Sell indirect
150,784
$26.49
$3.99M
Gold Daniel Allen
13 Feb 2026
Director
Sell indirect
225,000
$26.50
$5.96M
Gold Daniel Allen
13 Feb 2026
Director
Sell indirect
150,784
$26.49
$3.99M
MANCHESTER KEITH S
13 Feb 2026
Director
Sell indirect
225,000
$26.50
$5.96M
MANCHESTER KEITH S
13 Feb 2026
Director
Sell indirect
150,784
$26.49
$3.99M
Venker Eric
13 Feb 2026
President & Immunovant CEO
Sold after exercise
200,000
$26.49
$5.30M
QVT Financial LP
12 Feb 2026
Director by Deputization
Sell indirect
275,000
$26.76
$7.36M
QVT Financial LP
12 Feb 2026
Director by Deputization
Sell indirect
150,000
$26.72
$4.01M
Gold Daniel Allen
12 Feb 2026
Director
Sell indirect
275,000
$26.76
$7.36M
Gold Daniel Allen
12 Feb 2026
Director
Sell indirect
150,000
$26.72
$4.01M
MANCHESTER KEITH S
12 Feb 2026
Director
Sell indirect
275,000
$26.76
$7.36M
MANCHESTER KEITH S
12 Feb 2026
Director
Sell indirect
150,000
$26.72
$4.01M
QVT Financial LP
11 Feb 2026
Director by Deputization
Sell indirect
425,000
$26.67
$11.33M
Gold Daniel Allen
11 Feb 2026
Director
Sell indirect
425,000
$26.67
$11.33M
MANCHESTER KEITH S
11 Feb 2026
Director
Sell indirect
425,000
$26.67
$11.33M
Sukhatme Mayukh
9 Feb 2026
President & CIO
Sold after exercise
339,441
$26.47
$8.99M
Venker Eric
12 Jan 2026
President & Immunovant CEO
Sold after exercise
200,000
$21.92
$4.38M
Sukhatme Mayukh
31 Dec 2025
President & CIO
Sold after exercise
1,018,995
$21.71
$22.12M
Sukhatme Mayukh
29 Dec 2025
President & CIO
Sold after exercise
311,873
$21.74
$6.78M
Venker Eric
24 Dec 2025
President & Immunovant CEO
Sold after exercise
75,000
$22.53
$1.69M
Venker Eric
23 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$22.45
$4.49M
Pulik Richard
23 Dec 2025
CFO
Sold after exercise
146,731
$22.39
$3.29M
Pulik Richard
23 Dec 2025
CFO
Sold after exercise
260,000
$22.45
$5.84M
QVT Financial LP
17 Dec 2025
Director by Deputization
Sell indirect
189,538
$23.17
$4.39M
QVT Financial LP
17 Dec 2025
Director by Deputization
Sell indirect
155,076
$23.02
$3.57M
QVT Financial LP
17 Dec 2025
Director by Deputization
Sell indirect
432,718
$23.05
$9.97M
MANCHESTER KEITH S
17 Dec 2025
Director
Sell indirect
189,538
$23.17
$4.39M
MANCHESTER KEITH S
17 Dec 2025
Director
Sell indirect
155,076
$23.02
$3.57M
MANCHESTER KEITH S
17 Dec 2025
Director
Sell indirect
432,718
$23.05
$9.97M
Gold Daniel Allen
17 Dec 2025
Director
Sell indirect
189,538
$23.17
$4.39M
Gold Daniel Allen
17 Dec 2025
Director
Sell indirect
155,076
$23.02
$3.57M
Gold Daniel Allen
17 Dec 2025
Director
Sell indirect
432,718
$23.05
$9.97M
Sukhatme Mayukh
17 Dec 2025
President & CIO
Sold after exercise
26,831
$23.09
$619.53K
QVT Financial LP
16 Dec 2025
Director by Deputization
Sell indirect
642,282
$23.08
$14.82M
QVT Financial LP
16 Dec 2025
Director by Deputization
Sell indirect
275,000
$22.93
$6.31M
MANCHESTER KEITH S
16 Dec 2025
Director
Sell indirect
642,282
$23.08
$14.82M
MANCHESTER KEITH S
16 Dec 2025
Director
Sell indirect
275,000
$22.93
$6.31M
Gold Daniel Allen
16 Dec 2025
Director
Sell indirect
642,282
$23.08
$14.82M
Gold Daniel Allen
16 Dec 2025
Director
Sell indirect
275,000
$22.93
$6.31M
Ramaswamy Vivek
15 Dec 2025
10% owner
Sold after exercise
353,745
$22.05
$7.80M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
943,527
$21.68
$20.46M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
566,116
$21.68
$12.27M
Gline Matthew
15 Dec 2025
CEO
Sold after exercise
230,357
$21.68
$4.99M
Ramaswamy Vivek
12 Dec 2025
10% owner
Sold after exercise
1,975,858
$21.96
$43.39M
Ramaswamy Vivek
11 Dec 2025
10% owner
Sold after exercise
774,142
$21.64
$16.75M
Venker Eric
9 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.85
$4.17M
QVT Financial LP
19 Nov 2025
Director by Deputization
Sell indirect
175,000
$20.24
$3.54M
QVT Financial LP
19 Nov 2025
Director by Deputization
Sell indirect
125,000
$20.16
$2.52M
QVT Financial LP
19 Nov 2025
Director by Deputization
Sell indirect
150,000
$20.20
$3.03M
QVT Financial LP
19 Nov 2025
Director by Deputization
Sell indirect
850,000
$20.25
$17.21M
Gold Daniel Allen
19 Nov 2025
Director
Sell indirect
175,000
$20.24
$3.54M
Gold Daniel Allen
19 Nov 2025
Director
Sell indirect
125,000
$20.16
$2.52M
Gold Daniel Allen
19 Nov 2025
Director
Sell indirect
150,000
$20.20
$3.03M
Gold Daniel Allen
19 Nov 2025
Director
Sell indirect
850,000
$20.25
$17.21M
MANCHESTER KEITH S
19 Nov 2025
Director
Sell indirect
175,000
$20.24
$3.54M
MANCHESTER KEITH S
19 Nov 2025
Director
Sell indirect
125,000
$20.16
$2.52M
MANCHESTER KEITH S
19 Nov 2025
Director
Sell indirect
150,000
$20.20
$3.03M
MANCHESTER KEITH S
19 Nov 2025
Director
Sell indirect
850,000
$20.25
$17.21M
Ramaswamy Vivek
17 Nov 2025
10% owner
Sell
539,650
$20.51
$11.07M
Ramaswamy Vivek
14 Nov 2025
10% owner
Sell
1,027,670
$20.33
$20.89M
Ramaswamy Vivek
13 Nov 2025
10% owner
Sell
287,283
$20.81
$5.98M
Venker Eric
7 Nov 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.22
$4.04M
Venker Eric
17 Oct 2025
President & Immunovant CEO
Sold after exercise
118,418
$17.06
$2.02M
Venker Eric
16 Oct 2025
President & Immunovant CEO
Sold after exercise
318,282
$17.05
$5.43M
Venker Eric
15 Oct 2025
President & Immunovant CEO
Sold after exercise
414,683
$16.93
$7.02M
Venker Eric
13 Oct 2025
President & Immunovant CEO
Sold after exercise
20,727
$16.25
$336.81K
Venker Eric
9 Oct 2025
President & Immunovant CEO
Sold after exercise
104,940
$16.30
$1.71M
Venker Eric
8 Oct 2025
President & Immunovant CEO
Sold after exercise
138,602
$16.20
$2.25M
Venker Eric
7 Oct 2025
President & Immunovant CEO
Sold after exercise
355,161
$16.15
$5.74M
Venker Eric
6 Oct 2025
President & Immunovant CEO
Sold after exercise
171,396
$16.34
$2.80M
Venker Eric
23 Sep 2025
President & Immunovant CEO
Sold on a plan
611,000
$14.83
$9.06M
Venker Eric
22 Sep 2025
President & Immunovant CEO
Sold after exercise
100,000
$15.01
$1.50M
Venker Eric
22 Sep 2025
President & Immunovant CEO
Sold after exercise
316,182
$14.99
$4.74M
Venker Eric
19 Sep 2025
President & Immunovant CEO
Sold after exercise
683,818
$14.95
$10.22M
Gline Matthew
18 Sep 2025
CEO
Buy
3,315
$15.07
$49.96K

What was left out

Form 4 filings counted 86
Amendments (4/A) skipped 0
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 54
Sales at will 64
Transactions with no price 0
Shares from compensation/vesting 36,421,102
History held since 17 Oct 2017